BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura

Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, A. K., Bhushan, S., Lopez, L. D. R., Sampat, D., Salah, Z., Hatoum, C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019434/
https://www.ncbi.nlm.nih.gov/pubmed/35464782
http://dx.doi.org/10.1155/2022/5603919
Descripción
Sumario:Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.

Ejemplares similares